These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24 related articles for article (PubMed ID: 15739627)
1. Cerebrospinal fluid and plasma concentrations of the inflammatory marker soluble CD27 in a large surgical population. Tigchelaar C; Cunningham JL; Rasmusson AJ; Thulin M; Burman J; Kema IP; Larsson A; Absalom AR iScience; 2024 Jun; 27(6):110036. PubMed ID: 38883839 [TBL] [Abstract][Full Text] [Related]
2. T cells compete by cleaving cell surface CD27 and blocking access to CD70-bearing APCs. Burchill MA; Tamburini BA; Kedl RM Eur J Immunol; 2015 Nov; 45(11):3140-9. PubMed ID: 26179759 [TBL] [Abstract][Full Text] [Related]
3. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448 [TBL] [Abstract][Full Text] [Related]
4. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies. Kara IO; Sahin B; Gunesacar R Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023 [TBL] [Abstract][Full Text] [Related]
5. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies. van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819 [TBL] [Abstract][Full Text] [Related]
6. Increased levels of CSF soluble CD27 in patients with primary central nervous system lymphoma. Murase S; Saio M; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T Cancer Lett; 1998 Oct; 132(1-2):181-6. PubMed ID: 10397472 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients. Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid soluble CD27 levels in children with non-Hodgkin lymphomas. Yalçin B; Canpinar H; Kutluk MT; Varan A; Akyüz C; Büyükpamukçu M Pediatr Hematol Oncol; 2004 Dec; 21(8):717-23. PubMed ID: 15739627 [TBL] [Abstract][Full Text] [Related]
9. Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells. Hooijkaas H; Adriaansen HJ; van Dongen JJ Cancer Treat Res; 1988; 38():149-71. PubMed ID: 2908594 [No Abstract] [Full Text] [Related]
10. Leptomeningeal metastases from leukemias and lymphomas. Nolan CP; Abrey LE Cancer Treat Res; 2005; 125():53-69. PubMed ID: 16211883 [TBL] [Abstract][Full Text] [Related]
11. EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid. van Bussel MTJ; Pluim D; Bol M; Beijnen JH; Schellens JHM; Brandsma D J Neurooncol; 2018 Mar; 137(1):1-10. PubMed ID: 29192390 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Chamberlain MC; Glantz M; Groves MD; Wilson WH Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682 [TBL] [Abstract][Full Text] [Related]